Literature DB >> 24446072

Bayesian modeling of cost-effectiveness studies with unmeasured confounding: a simulation study.

James D Stamey1, Daniel P Beavers, Douglas Faries, Karen L Price, John W Seaman.   

Abstract

Unmeasured confounding is a common problem in observational studies. Failing to account for unmeasured confounding can result in biased point estimators and poor performance of hypothesis tests and interval estimators. We provide examples of the impacts of unmeasured confounding on cost-effectiveness analyses using observational data along with a Bayesian approach to correct estimation. Assuming validation data are available, we propose a Bayesian approach to correct cost-effectiveness studies for unmeasured confounding. We consider the cases where both cost and effectiveness are assumed to have a normal distribution and when costs are gamma distributed and effectiveness is normally distributed. Simulation studies were conducted to determine the impact of ignoring the unmeasured confounder and to determine the size of the validation data required to obtain valid inferences.
Copyright © 2013 John Wiley & Sons, Ltd.

Keywords:  cost-effectiveness; simulation; validation data

Mesh:

Year:  2013        PMID: 24446072     DOI: 10.1002/pst.1604

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  2 in total

1.  On the censored cost-effectiveness analysis using copula information.

Authors:  Charles Fontaine; Jean-Pierre Daurès; Paul Landais
Journal:  BMC Med Res Methodol       Date:  2017-02-15       Impact factor: 4.615

2.  Illustration of the Impact of Unmeasured Confounding Within an Economic Evaluation Based on Nonrandomized Data.

Authors:  Jason R Guertin; James M Bowen; Guy De Rose; Daria J O'Reilly; Jean-Eric Tarride
Journal:  MDM Policy Pract       Date:  2017-03-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.